Identification of Medicinal Products (IDMP) Standards Part 1: Impact on the Regulatory World

Posted 21 December 2016 By Dieter Schlaps

placeholder+image This is part one of a four-part series on the Identification of Medicinal Products (IDMP) standards and their respective implementation guidelines. This segment reviews the steps needed to prepare for their global implementation and offers technical solution options for the industry.

Share this article:

Categories: Biologics and biotechnology, Drugs, News, US, Europe, FDA, EMA, ISO

Tags: ISO IDMP, IDMP, Identification of Medicinal Products

Regulatory Exchange: Latest Updates From the Community